Figure 3
From: Rho GTPase gene expression and breast cancer risk: a Mendelian randomization analysis
Results of MR analyses performed for overall, ER+ and ER− breast cancer risk for RHOD and CDC42. The genetic instruments for RHOD were obtained from breast mammary tissue (GTEx) (A) and from blood (eQTLGen) (B) and for CDC42 were obtained from blood (eQTLGen) (C) and from breast cancer tissue (TCGA) (D). BC breast cancer, OR odds ratio, CI confidence interval.
